Myriad Genetics, Inc. is a company in the U.S. stock market and it is a holding in 77 U.S.-traded ETFs. MYGN has around 14.4M shares in the U.S. ETF market. The largest ETF holder of MYGN is the iShares Core S&P Small-Cap ETF (IJR), with approximately 4.58M shares. Investors may also find of interest that the ETF with the largest allocation to MYGN stock is Invesco S&P SmallCap Health Care ETF (PSCH), with a portfolio weight of 1.86%. On average, U.S. ETFs allocate 0.18% of MYGN to their portfolios.
Additionally, MYGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MYGN as a holding is the Fidelity NASDAQ Composite Index Tracking Stock (ONEQ), with a return of 16.07%.